Asia Pacific Artificial Intelligence (AI) in Medical Diagnostics Market Size, Share & Industry Trends Analysis Report by Application (In Vivo Diagnostics and In Vitro Diagnostics), End-user, Component (Services and Software), Country and Growth Forecast, 2022-2028

The Asia Pacific Artificial Intelligence (AI) in Medical Diagnostics Market should witness market growth of 41.0% CAGR during the forecast period (2022-2028).

Artificial Intelligence, or AI, is becoming increasingly prevalent in the medical industry, particularly in diagnosis and therapy management. Recently, a massive number of research studies have been done on how AI might aid clinical judgments and improve clinicians' judgment. Accurate diagnosis is a vital component of healthcare systems worldwide. Additionally, a number of outpatients throughout the world obtain an inaccurate diagnosis, with errors being particularly prevalent for serious medical diseases and posing a risk of severe patient harm.

In recent years, machine learning and artificial intelligence have developed into potent diagnostic aids. This technology could transform healthcare by enabling more accurate diagnostics. The new method addresses the limitations of its predecessors by incorporating causal reasoning into machine learning. Traditionally, the diagnosis was exclusively based on connections between symptoms and the most probable reason.

Using artificial intelligence, researchers are advancing cardiovascular health at multiple institutions. Hospitals and research institutions will use artificial intelligence to program computers to analyze and respond to data swiftly and precisely for improved treatment outcomes. Programs are capable of detecting heart problems, treating strokes, and boosting diagnostic radiography capabilities, among other duties. Personalized computational modeling of patient hearts is making progress in generating models that account for the individual geometry and structure of the heart in addition to other patient-specific data.

The adoption of AI is increasing at a rapid pace throughout the region. According to the Ministry of IT and Electronics, the Indian government has adopted a number of measures to encourage upskilling and reskilling in the artificial intelligence field. In conjunction with NASSCOM, the Ministry of Electronics and IT has launched FutureSkills PRIME, a B2C framework for re-skilling/ up-skilling of IT experts in 10 sectors. Emerging technologies comprise Artificial Intelligence. The government issued the National Strategy for Artificial Intelligence in June 2018 and plans to establish an ecosystem for the study and application of AI. With the constantly increasing adoption of AI technologies in India, the demand for AI in medical diagnosis would also increase and this factor would boost the growth of the regional market.

The China market dominated the Asia Pacific Artificial Intelligence (AI) in Medical Diagnostics Market by Country in 2021; thereby, achieving a market value of $543 million by 2028. The Japan market is registering a CAGR of 40.1% during (2022-2028). Additionally, The India market would showcase a CAGR of 41.9% during (2022-2028).

Based on Application, the market is segmented into In Vivo Diagnostics and In Vitro Diagnostics. Based on Vivo Diagnostics Specialty Type, the market is segmented into Radiology, Cardiology, Neurology, Obstetrics/gynecology, Ophthalmology and Others. Based on Vivo Diagnostics Modality Type, the market is segmented into Computed Tomography, X-Ray & Ultrasound, Magnetic Resonance Imaging and Others. Based on End-user, the market is segmented into In Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories and Others. Based on Component, the market is segmented into Services and Software. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Nvidia Corporation, IBM Corporation, Intel Corporation, Google LLC, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Xilinx, Inc., Digital Diagnostics, Inc. and InformAI, LLC

Scope of the Study

By Application

• In Vivo Diagnostics
  • Vivo Diagnostics Specialty Type
    • Radiology
    • Cardiology
    • Neurology
    • Obstetrics/gynecology
    • Ophthalmology
    • Others
  • Vivo Diagnostics Modality Type
    • Computed Tomography
    • X-Ray & Ultrasound
    • Magnetic Resonance Imaging
    • Others
  • In Vitro Diagnostics

By End-user

• Hospitals
• Diagnostics Imaging Centers
• Diagnostics Laboratories
• Others

By Component

• Services
• Software

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Microsoft Corporation
• Nvidia Corporation
• IBM Corporation
• Intel Corporation
• Google LLC
• Siemens Healthineers AG (Siemens AG)
• General Electric (GE) Co. (GE Healthcare)
• Xilinx, Inc.
• Digital Diagnostics, Inc.
• InformAI, LLC

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free